Current Problems in Cardiology
Volume 32, Issue 10 , Pages 553-599 , October 2007

The Surgical Treatment of End-Stage Heart Failure

References 

  1. Kumpati GS, McCarthy PM, Hoercher KJ. Surgical treatments for heart failure. Cardiol Clin. 2001;19:669–681
  2. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397–1402
  3. Cohn JN. Structural basis for heart failure (Ventricular remodeling and its pharmacological inhibition). Circulation. 1995;91:2504–2507
  4. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821–828
  5. CIBIS Investigators and Committees. A randomized trial of beta-blockade in heart failure (The Cardiac Insufficiency Bisoprolol Study (CIBIS)). Circulation. 1994;90:1765–1773
  6. Australia/New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet. 1997;349:375–380
  7. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13
  8. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–2007
  9. Aikawa Y, Rohde L, Plehn J, et al. Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysis. Am Heart J. 2001;141:234–242
  10. Kober L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction (Trandolapril Cardiac Evaluation (TRACE) Study Group). N Engl J Med. 1995;333:1670–1676
  11. Konstam MA, Kronenberg MW, Rousseau MF, et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction (SOLVD (Studies of Left Ventricular Dysfunction) Investigators). Circulation. 1993;88:2277–2283
  12. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure (U.S. Carvedilol Heart Failure Study Group). N Engl J Med. 1996;334:1349–1355
  13. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–1658
  14. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327:669–677
  15. Yancy CW, Fowler MB, Colucci WS, et al. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med. 2001;344:1358–1365
  16. OPTN Transplant Information Database. Organ Procurement and Transplantation Network, http://www.optn.org/data, 2006.
  17. Keck B, Bennet LE, Rosendale J. Worldwide Thoracic Organ Transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation. In:  Cecka J,  Terasaki PI editor. Clinical Transplants. Richmond, VA: UNOS; 2000;p. 35–49
  18. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293–302
  19. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525–533
  20. Franciosa JA, Wilen M, Ziesche S, et al. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983;51:831–836
  21. Luciani GB, Faggian G, Razzolini R, et al. Severe ischemic left ventricular failure: coronary operation or heart transplantation?. Ann Thorac Surg. 1993;55:719–723
  22. Langenburg SE, Buchanan SA, Blackbourne LH, et al. Predicting survival after coronary revascularization for ischemic cardiomyopathy. Ann Thorac Surg. 1995;60:1193–1196discussion 1196-7
  23. Diamond GA, Forrester JS, deLuz PL, et al. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J. 1978;95:204–209
  24. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211–221
  25. Montalescot G, Faraggi M, Drobinski G, et al. Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia. Circulation. 1992;86:47–55
  26. Braunwald E, Hollingsworth C, Passamani E. NHLBI workshop on surgery in the treatment of coronary artery disease. Circulation. 1985;72:1–168
  27. Yoshida K, Gould KL. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol. 1993;22:984–997
  28. Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151–1158
  29. Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg. 1998;116:997–1004
  30. La Canna G, Rahimtoola SH, Visioli O, et al. Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J. 2000;21:1358–1367
  31. Louie HW, Laks H, Milgalter E, et al. Ischemic cardiomyopathy (Criteria for coronary revascularization and cardiac transplantation). Circulation. 1991;84:III290–III295
  32. Bonow RO. Identification of viable myocardium. Circulation. 1996;94:2674–2680
  33. Di Carli MF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 1994;73:527–533
  34. La Canna G, Alfieri O, Giubbini R, et al. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:617–626
  35. Rocchi G, Poldermans D, Bax JJ, et al. Usefulness of the ejection fraction response to dobutamine infusion in predicting functional recovery after coronary artery bypass grafting in patients with left ventricular dysfunction. Am J Cardiol. 2000;85:1440–1444
  36. Vanoverschelde JL, Gerber BL, D’Hondt AM, et al. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization (Role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT). Circulation. 1995;92:II37–II44
  37. Arnese M, Cornel JH, Salustri A, et al. Prediction of improvement of regional left ventricular function after surgical revascularization (A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography). Circulation. 1995;91:2748–2752
  38. Haas F, Jennen L, Heinzmann U, et al. Ischemically compromised myocardium displays different time-courses of functional recovery: correlation with morphological alterations?. Eur J Cardiothorac Surg. 2001;20:290–298
  39. Kron IL, Flanagan TL, Blackbourne LH, et al. Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. Ann Surg. 1989;210:348–352discussion 352-4
  40. Sedlis SP, Ramanathan KB, Morrison DA, et al. Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry). Am J Cardiol. 2004;94:118–120
  41. Kron IL, Cope JT, Baker LD, et al. The risks of reoperative coronary artery bypass in chronic ischemic cardiomyopathy: results of the CABG Patch Trial. Circulation. 1997;96:II-21–II-25
  42. Elefteriades J, Edwards R. Coronary bypass in left heart failure. Semin Thorac Cardiovasc Surg. 2002;14:125–132
  43. Hausmann H, Topp H, Siniawski H, et al. Decision-making in end-stage coronary artery disease: revascularization or heart transplantation?. Ann Thorac Surg. 1997;64:1296–1301discussion 1302
  44. Tjan TD, Kondruweit M, Scheld HH, et al. The bad ventricle—revascularization versus transplantation. Thorac Cardiovasc Surg. 2000;48:9–14
  45. Elefteriades JA, Tolis G, Levi E, et al. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol. 1993;22:1411–1417
  46. Dupuis JY, Bondy R, Cattran C, et al. Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome. J Cardiothorac Vasc Anesth. 1992;6:542–553
  47. Flack JE, Cook JR, May SJ, et al. Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? (Results from the CABG Patch Trial). Circulation. 2000;102:III84–III89
  48. Westaby S. Coronary revascularization in ischemic cardiomyopathy. Surg Clin North Am. 2004;84:179–199x
  49. Koelling TM, Aaronson KD, Cody RJ, et al. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J. 2002;144:524–529
  50. Otto CM. Clinical practice (Evaluation and management of chronic mitral regurgitation). N Engl J Med. 2001;345:740–746
  51. Robbins JD, Maniar PB, Cotts W, et al. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol. 2003;91:360–362
  52. Trichon BH, Felker GM, Shaw LK, et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91:538–543
  53. Kono T, Sabbah HN, Rosman H, et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol. 1992;20:1594–1598
  54. Yiu SF, Enriquez-Sarano M, Tribouilloy C, et al. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation. 2000;102:1400–1406
  55. Braunwald E. A Textbook of Cardiovascular Medicine. 4th ed.. Philadelphia, PA: Saunders; 1992;
  56. Patel JB, Borgeson DD, Barnes ME, et al. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail. 2004;10:285–291
  57. Bach DS, Bolling SF. Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty. Am J Cardiol. 1996;78:966–969
  58. Badhwar V, Bolling SF. Mitral valve surgery in the patient with left ventricular dysfunction. Semin Thorac Cardiovasc Surg. 2002;14:133–136
  59. Bax JJ, Braun J, Somer ST, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation. 2004;110:II103–II108
  60. Bishay ES, McCarthy PM, Cosgrove DM, et al. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg. 2000;17:213–221
  61. Bolling SF, Pagani FD, Deeb GM, et al. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg. 1998;115:381–386discussion 387-8
  62. Gummert JF, Rahmel A, Bucerius J, et al. Mitral valve repair in patients with end stage cardiomyopathy: who benefits?. Eur J Cardiothorac Surg. 2003;23:1017–1022discussion 1022
  63. Romano MA, Bolling SF. Update on mitral repair in dilated cardiomyopathy. J Card Surg. 2004;19:396–400
  64. Tibayan FA, Rodriguez F, Langer F, et al. Undersized mitral annuloplasty alters left ventricular shape during acute ischemic mitral regurgitation. Circulation. 2004;110:II98–II102
  65. Badhwar V, Bolling SF. Mitral valve surgery: when is it appropriate?. Congest Heart Fail. 2002;8:210–213
  66. Bolling SF. Mitral reconstruction in cardiomyopathy. J Heart Valve Dis. 2002;11(Suppl 1):S26–S31
  67. Smolens IA, Pagani FD, Bolling SF. Mitral valve repair in heart failure. Eur J Heart Fail. 2000;2:365–371
  68. Acker MA, Bolling S, Shemin R, et al. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg. 2006;132:568–577e1-4
  69. Mann DL, Acker MA, Jessup M, et al. Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York health association class III-IV heart failure. J Card Fail. 2004;10:185–192
  70. Wu AH, Aaronson KD, Bolling SF, et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45:381–387
  71. Calafiore AM, Gallina S, Di Mauro M, et al. Mitral valve procedure in dilated cardiomyopathy: repair or replacement?. Ann Thorac Surg. 2001;71:1146–1152discussion 1152-3
  72. Calafiore AM, Di Mauro M, Gallina S, et al. Mitral valve surgery for chronic ischemic mitral regurgitation. Ann Thorac Surg. 2004;77:1989–1997
  73. Thourani VH, Weintraub WS, Guyton RA, et al. Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation. 2003;108:298–304
  74. Grossi EA, Bizekis CS, LaPietra A, et al. Late results of isolated mitral annuloplasty for “functional” ischemic mitral insufficiency. J Card Surg. 2001;16:328–332
  75. Fukamachi K, Inoue M, Popovic ZB, et al. Off-pump mitral valve repair using the Coapsys device: a pilot study in a pacing-induced mitral regurgitation model. Ann Thorac Surg. 2004;77:688–692discussion 692-3
  76. Grossi EA, Saunders PC, Woo YJ, et al. Intraoperative effects of the coapsys annuloplasty system in a randomized evaluation (RESTOR-MV) of functional ischemic mitral regurgitation. Ann Thorac Surg. 2005;80:1706–1711
  77. Mishra YK, Mittal S, Jaguri P, et al. Coapsys mitral annuloplasty for chronic functional ischemic mitral regurgitation: 1-year results. Ann Thorac Surg. 2006;81:42–46
  78. Messas E, Guerrero JL, Handschumacher MD, et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation. 2001;104:1958–1963
  79. Messas E, Pouzet B, Touchot B, et al. Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation. Circulation. 2003;108(Suppl 1):II111–II115
  80. Rodriguez F, Langer F, Harrington KB, et al. Cutting second-order chords does not prevent acute ischemic mitral regurgitation. Circulation. 2004;110:II91–II97
  81. Rodriguez F, Langer F, Harrington KB, et al. Importance of mitral valve second-order chordae for left ventricular geometry, wall thickening mechanics, and global systolic function. Circulation. 2004;110:II115–II122
  82. Kron IL, Green GR, Cope JT. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg. 2002;74:600–601
  83. Kongsaerepong V, Qin JX, Song JM, et al. Comparison between successful and failure mitral valve repair in ischemic mitral regurgitation: an intraoperative echocardiographic study. J Am Soc Echocardiogr. 2004;17:507
  84. Daimon M, Shiota T, Gillinov AM, et al. Percutaneous mitral valve repair for chronic ischemic mitral regurgitation: a real-time three-dimensional echocardiographic study in an ovine model. Circulation. 2005;111:2183–2189
  85. Kaye DM, Byrne M, Alferness C, et al. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation. Circulation. 2003;108:1795–1797
  86. Liddicoat JR, Mac Neill BD, Gillinov AM, et al. Percutaneous mitral valve repair: a feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv. 2003;60:410–416
  87. Cooley DA, Henly WS, Amad KH, et al. Ventricular aneurysm following myocardial infarction: results of surgical treatment. Ann Surg. 1959;150:595–612
  88. Dor V, Kreitmann P, Jourdan J. Interest in physiologic closure of left ventricle after resection and endocardiectomy for aneurysm of akinetic zone comparison with classical technique about a series of 209 left ventricle resections. J Cardiovasc Surg. 1985;26:73
  89. Jatene AD. Left ventricular aneurysmectomy (Resection or reconstruction). J Thorac Cardiovasc Surg. 1985;89:321–331
  90. Cooley DA. Ventricular endoaneurysmorrhaphy: a simplified repair for extensive postinfarction aneurysm. J Card Surg. 1989;4:200–205
  91. Athanasuleas CL, Buckberg GD, Stanley AW, et al. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol. 2004;44:1439–1445
  92. Athanasuleas CL, Stanley AW, Buckberg GD, et al. Surgical anterior ventricular endocardial restoration (SAVER) for dilated ischemic cardiomyopathy. Semin Thorac Cardiovasc Surg. 2001;13:448–458
  93. Athanasuleas CL, Stanley AW, Buckberg GD, et al. Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. RESTORE group. Reconstructive Endoventricular Surgery, returning Torsion Original Radius Elliptical Shape to the LV. J Am Coll Cardiol. 2001;37:1199–1209
  94. Di Donato M, Sabatier M, Dor V, et al. Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery. J Thorac Cardiovasc Surg. 2001;121:91–96
  95. Dor V, Di Donato M, Sabatier M, et al. Left ventricular reconstruction by endoventricular circular patch plasty repair: a 17-year experience. Semin Thorac Cardiovasc Surg. 2001;13:435–447
  96. Dor V, Saab M, Coste P, et al. Left ventricular aneurysm: a new surgical approach. Thorac Cardiovasc Surg. 1989;37:11–19
  97. Dor V, Sabatier M, Di Donato M, et al. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg. 1998;116:50–59
  98. Mickleborough LL, Carson S, Ivanov J. Repair of dyskinetic or akinetic left ventricular aneurysm: results obtained with a modified linear closure. J Thorac Cardiovasc Surg. 2001;121:675–682
  99. Menicanti L, Di Donato M. The Dor procedure: what has changed after fifteen years of clinical practice?. J Thorac Cardiovasc Surg. 2002;124:886–890
  100. Bogaert J, Bosmans H, Maes A, et al. Remote myocardial dysfunction after acute anterior myocardial infarction: impact of left ventricular shape on regional function: a magnetic resonance myocardial tagging study. J Am Coll Cardiol. 2000;35:1525–1534
  101. Di Donato M, Sabatier M, Toso A, et al. Regional myocardial performance of non-ischaemic zones remote from anterior wall left ventricular aneurysm (Effects of aneurysmectomy). Eur Heart J. 1995;16:1285–1292
  102. Maxey TS, Reece TB, Ellman PI, et al. Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2004;127:428–434
  103. Menicanti L, Di Donato M, Frigiola A, et al. Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration. J Thorac Cardiovasc Surg. 2002;123:1041–1050
  104. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med. 1984;311:1333–1339
  105. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629–1646
  106. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med. 1988;319:332–337
  107. Joyce D, Loebe M, Noon GP, et al. Revascularization and ventricular restoration in patients with ischemic heart failure: the STICH trial. Curr Opin Cardiol. 2003;18:454–457
  108. Menicanti L, Di Donato M. Surgical left ventricle reconstruction, pathophysiologic insights, results and expectation from the STICH trial. Eur J Cardiothorac Surg. 2004;26(Suppl 1):S42–S46discussion S46-7
  109. Maxey TS, Keeling WB, Sommers KE. Surgical alternatives for the palliation of heart failure: a prospectus. J Card Fail. 2005;11:670–676
  110. Patel HJ, Polidori DJ, Pilla JJ, et al. Stabilization of chronic remodeling by asynchronous cardiomyoplasty in dilated cardiomyopathy: effects of a conditioned muscle wrap. Circulation. 1997;96:3665–3671
  111. Chaudhry PA, Mishima T, Sharov VG, et al. Passive epicardial containment prevents ventricular remodeling in heart failure. Ann Thorac Surg. 2000;70:1275–1280
  112. Sabbah HN, Sharov VG, Chaudhry PA, et al. Chronic therapy with the acorn cardiac support device in dogs with chronic heart failure: three and six months hemodynamic, histologic and ultrastructural findings. J Heart Lung Transplant. 2001;20189:
  113. Kleber F, Sonntag S, Krebs H, et al. Follow-up on passive cardiomyoplasty in congestive heart failure: influence on the Acorn Cardiac Support Device on left ventricular function. [abstract] J Am Coll Cardiol. 2001;37(Suppl 1):143
  114. Mann DL, Acker MA, Jessup M, et al. Clinical evaluation of the CorCap™ Cardiac Support Device in patients with dilated cardiomyopathy. Ann Thorac Surg. 2006;(in press)
  115. Blom AS, Mukherjee R, Pilla JJ, et al. Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction. Circulation. 2005;112:1274–1283
  116. Blom AS, Pilla JJ, Gorman RC, et al. Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep. Heart Fail Rev. 2005;10:125–139
  117. Pilla JJ, Blom AS, Brockman DJ, et al. Ventricular constraint using the acorn cardiac support device reduces myocardial akinetic area in an ovine model of acute infarction. Circulation. 2002;106:I207–I211
  118. Pilla JJ, Blom AS, Gorman JH, et al. Early postinfarction ventricular restraint improves borderzone wall thickening dynamics during remodeling. Ann Thorac Surg. 2005;80:2257–2262
  119. Klodell CT, McGiffin DC, Rayburn BK, et al. Initial experience with the paracor Cardiac Support Device. AATS 86th annual meeting. 2006;Philadelphia, PA
  120. Fukamachi K, McCarthy PM. Initial safety and feasibility clinical trial of the myosplint device. J Card Surg. 2005;20:S43–S47
  121. Fukamachi K, Popovic ZB, Inoue M, et al. Changes in mitral annular and left ventricular dimensions and left ventricular pressure-volume relations after off-pump treatment of mitral regurgitation with the Coapsys device. Eur J Cardiothorac Surg. 2004;25:352–357
  122. DeBakey ME. Left ventricular bypass pump for cardiac assistance (Clinical experience). Am J Cardiol. 1971;27:3–11
  123. Cooley DA, Liotta D, Hallman GL, et al. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol. 1969;24:723–730
  124. DeVries WC, Anderson JL, Joyce LD, et al. Clinical use of the total artificial heart. N Engl J Med. 1984;310:273–278
  125. Catanese KA, Goldstein DJ, Williams DL, et al. Outpatient left ventricular assist device support: a destination rather than a bridge. Ann Thorac Surg. 1996;62:646–652discussion 653
  126. Frazier OH, Rose EA, Macmanus Q, et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg. 1992;53:1080–1090
  127. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med. 1998;339:1522–1533
  128. Korfer R, El-Banayosy A, Arusoglu L, et al. Single-center experience with the thoratec ventricular assist device. J Thorac Cardiovasc Surg. 2000;119:596–600
  129. McBride LR, Naunheim KS, Fiore AC, et al. Clinical experience with 111 thoratec ventricular assist devices. Ann Thorac Surg. 1999;67:1233–1238discussion 1238-9
  130. Moskowitz AJ, Weinberg AD, Oz MC, et al. Quality of life with an implanted left ventricular assist device. Ann Thorac Surg. 1997;64:1764–1769
  131. Pennington DG, McBride LR, Peigh PS, et al. Eight years’ experience with bridging to cardiac transplantation. J Thorac Cardiovasc Surg. 1994;107:472–480discussion 480-1
  132. Portner PM, Oyer PE, Pennington DG, et al. Implantable electrical left ventricular assist system: bridge to transplantation and the future. Ann Thorac Surg. 1989;47:142–150
  133. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435–1443
  134. Park SJ, Tector A, Piccioni W, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg. 2005;129:9–17
  135. Long JW, Kfoury AG, Slaughter MS, et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail. 2005;11:133–138
  136. Rogers JG, Pierson RN, Butler J, et al. Long-term results with the Novacor left ventricular assist device in non-transplant candidates: results of the INTrEPID Trial. (Abstract) 2005 American Heart Association Scientific Sessions. 2005;Dallas, TX
  137. Frazier OH, Myers TJ, Gregoric ID, et al. Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation. 2002;105:2855–2860
  138. Westaby S, Banning AP, Saito S, et al. Circulatory support for long-term treatment of heart failure: experience with an intraventricular continuous flow pump. Circulation. 2002;105:2588–2591
  139. Frazier OH. Implantation of the Jarvik 2000 left ventricular assist device without the use of cardiopulmonary bypass. Ann Thorac Surg. 2003;75:1028–1030
  140. Frazier OH, Delgado RM. Mechanical circulatory support for advanced heart failure: where does it stand in 2003?. Circulation. 2003;108:3064–3068
  141. Kormos RL, Strueber M, Frazier OH, et al. Heartmate II Axial Flow Left Ventricular Assist Device: suitability for advanced congestive heart failure. American Heart Association Scientific Sessions. 2005;Dallas, TX

PII: S0146-2806(07)00096-5

doi: 10.1016/j.cpcardiol.2007.08.001

Current Problems in Cardiology
Volume 32, Issue 10 , Pages 553-599 , October 2007

Article Tools

* Image Usage & Resolution